Wells Messersmith, MD
Medical Oncology · Aurora, CONPI 1760431472
Payments from drug & device makers
Across 250 payments — averaging $25,236 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2.6M
- Exelixis Inc.$905K
- Bristol Myers Squibb$884K
- Pfizer$878K
- AstraZeneca$344K
- Beigene, Ltd.$259K
- plus $391K from 8 others
Across 7 payments — averaging $1185.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$7K
- Amgen$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 7 | $2,648,180 |
| Exelixis Inc. | 6 | $904,750 |
| Bristol Myers Squibb | 6 | $884,346 |
| Pfizer | 86 | $877,832 |
| AstraZeneca | 14 | $344,110 |
| Beigene, Ltd. | 91 | $259,172 |
| Incyte Corporation | 9 | $165,515 |
| Immunomedics, Inc. | 4 | $109,397 |
| Novartis | 3 | $99,463 |
| Amgen | 16 | $12,100 |
| Taiho Oncology, Inc. | 5 | $2,644 |
| QED Therapeutics, Inc. | 1 | $800 |
| Gilead | 1 | $615 |
| Natus Medical Incorporated | 1 | $13 |
How this compares
$6,308,936 in reported general payments places this provider in the 90th percentile of 96 medical oncology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Aurora
- Karl LewisAurora$12.4M
- Christopher LieuAurora$8M
- David CamidgeAurora$7.3M
- Theresa MedinaAurora$7M
- Antonio JimenoAurora$5.6M
- Elizabeth KesslerAurora$5.1M
- Sarah DavisAurora$3.9M
- Sunnie KimAurora$3.9M
- Peter KabosAurora$3.5M
- Robert LentzAurora$3.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.